- Home
- ASRT vs APLT Comparison
ASRT vs APLT Comparison
Compare ASRT & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- APLT
- Stock Information
- Founded
- ASRT 1995
- APLT 2016
- Country
- ASRT United States
- APLT United States
- Employees
- ASRT N/A
- APLT N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- APLT Health Care
- Exchange
- ASRT Nasdaq
- APLT Nasdaq
- Market Cap
- ASRT 79.1M
- APLT 63.6M
- IPO Year
- ASRT 1997
- APLT 2019
- Fundamental
- Price
- ASRT $0.95
- APLT $0.41
- Analyst Decision
- ASRT Strong Buy
- APLT Buy
- Analyst Count
- ASRT 1
- APLT 6
- Target Price
- ASRT $3.00
- APLT $6.10
- AVG Volume (30 Days)
- ASRT 222.4K
- APLT 771.9K
- Earning Date
- ASRT 11-10-2025
- APLT 11-06-2025
- Dividend Yield
- ASRT N/A
- APLT N/A
- EPS Growth
- ASRT N/A
- APLT N/A
- EPS
- ASRT N/A
- APLT N/A
- Revenue
- ASRT $117,099,000.00
- APLT $121,000.00
- Revenue This Year
- ASRT N/A
- APLT N/A
- Revenue Next Year
- ASRT $5.84
- APLT $5,931.24
- P/E Ratio
- ASRT N/A
- APLT N/A
- Revenue Growth
- ASRT N/A
- APLT N/A
- 52 Week Low
- ASRT $0.51
- APLT $0.30
- 52 Week High
- ASRT $1.38
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ASRT 76.35
- APLT 38.50
- Support Level
- ASRT $0.79
- APLT $0.40
- Resistance Level
- ASRT $0.83
- APLT $0.46
- Average True Range (ATR)
- ASRT 0.04
- APLT 0.03
- MACD
- ASRT 0.01
- APLT -0.01
- Stochastic Oscillator
- ASRT 88.81
- APLT 7.74
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.